LC/MS dMRM Method Refinement Expands Targeted Lipidomics Studies from Plasma to Cells and Tissues

Applications | 2026 | Agilent TechnologiesInstrumentation
LC/MS, LC/MS/MS, LC/QQQ
Industries
Lipidomics, Clinical Research
Manufacturer
Agilent Technologies
Downloadable PDF for viewing
 

Similar PDF

A Comprehensive, Curated, High‑Throughput Method for the Detailed Analysis of the Plasma Lipidome
Targeted Lipidomic Analysis of Pediatric Leukemia Cells Using LC-MS/MS Triple Quadrupole
Targeted Lipidomic Analysis in Human Milk Using LC-MS/MSTriple Quadrupole
Multi-Omics for Plasma: A Three-in-One End-to-End Automated Sample Preparation and LC/MS Metabolomics, Lipidomics, and Proteomics Workflow